Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Johnson and Johnson
US Army
Cerilliant
Harvard Business School
Merck
McKinsey
UBS
Baxter
Fish and Richardson

Generated: January 16, 2018

DrugPatentWatch Database Preview

IPLEX Drug Profile

« Back to Dashboard

When do Iplex patents expire, and when can generic versions of Iplex launch?

Iplex is a drug marketed by Insmed and is included in one NDA.

The generic ingredient in IPLEX is mecasermin rinfabate recombinant. Additional details are available on the mecasermin rinfabate recombinant profile page.
Summary for IPLEX
US Patents:0
Applicants:1
NDAs:1
Drug Prices:see details
DailyMed Link:IPLEX at DailyMed
Drug patent expirations by year for IPLEX

US Patents and Regulatory Information for IPLEX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Insmed IPLEX mecasermin rinfabate recombinant INJECTABLE;SUBCUTANEOUS 021884-001 Dec 12, 2005 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for IPLEX

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Insmed IPLEX mecasermin rinfabate recombinant INJECTABLE;SUBCUTANEOUS 021884-001 Dec 12, 2005 ➤ Subscribe ➤ Subscribe
Insmed IPLEX mecasermin rinfabate recombinant INJECTABLE;SUBCUTANEOUS 021884-001 Dec 12, 2005 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Moodys
UBS
Queensland Health
Fish and Richardson
Colorcon
Citi
Fuji
Accenture
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot